Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Are peptides legal in Tennessee?

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

The short answer

Yes. A Tennessee resident can obtain FDA approved peptides such as semaglutide and tirzepatide from a Tennessee-licensed prescriber, including by telehealth under Tennessee Code section 63-1-155, and can obtain a compounded peptide when it is eligible under federal 503A rules and dispensed by a pharmacy licensed by the Tennessee Board of Pharmacy. Tennessee tightened compounding oversight after the 2012 fungal meningitis outbreak: section 63-10-216 requires out-of-state compounding pharmacies to submit a home-state inspection from the previous 12 months before licensure, and Board rule chapter 1140-07 sets sterile compounding standards that cover injectable peptides.

Regulatory: Telehealth allowedRegulatory: Async allowedRegulatory: Compounded GLP-1 limitedVerified: Verified Oct 4, 2026
Compounding rules
Follows the federal 503A framework
Telehealth prescribing
Allowed, asynchronous allowed; a questionnaire alone is not enough
Compounded GLP-1
Limited

Can a Tennessee resident get peptides by telehealth?

Tennessee Code section 63-1-155 governs telehealth for licensed healthcare providers. It defines telehealth to include both real-time audio or video and store-and-forward telemedicine services, meaning asynchronous computer-based communications between provider and patient. Under section 63-1-155(b) the provider-patient relationship is not created simply by a provider receiving health information; it takes mutual consent and mutual communication. The provider is held to the same standard of practice as in person. Licensing boards may not set a stricter standard for telehealth than the practice act allows. For physicians, Board of Medical Examiners Rule 0880-02-.16(6) allows the encounter that establishes the relationship to take place by telemedicine with no facilitator present, so long as the patient uses technology that lets the physician verify identity and location, the patient transmits all relevant health information at the level of store-and-forward technology or secure video conferencing, and the physician discloses name, practice location and credentials. The rule says telemedicine is not an audio-only phone call, email, instant messaging or fax, and a patient under 18 needs a facilitator. Board Rule 0880-02-.14(7)(c) makes it a prima facie violation for a physician to prescribe based solely on answers to a set of questions, whether in person, over the Internet, or by telephone, without the history, examination, diagnosis, and treatment plan the rule requires. Both Board rules apply to physicians (MDs). The prescriber must hold a Tennessee license, and section 63-1-155 does not cover pain management clinics or chronic nonmalignant pain treatment. This record classifies asynchronous prescribing as allowed because the statute includes store-and-forward in telehealth and Rule 0880-02-.16(6) expressly lets the relationship be established with store-and-forward information, subject to the same standard of care as in person. It classifies a questionnaire alone as barred because Rule 0880-02-.14(7)(c) bars prescribing based solely on answers to a set of questions. How that bar applies inside a telemedicine encounter that meets Rule 0880-02-.16(6) is open to argument, because that rule applies notwithstanding Rule 0880-02-.14(7). [2] [4]

How does the Tennessee pharmacy board treat compounding?

Compounding regulator for Tennessee
BoardTennessee Board of Pharmacy (Tennessee Department of Health)
Eligible substancesFollows the federal 503A framework

The Tennessee Board of Pharmacy licenses pharmacies under title 63, chapter 10 of the Tennessee Code. Section 63-10-216 is a compounding-specific statute: an out-of-state pharmacy must be inspected by its home-state regulator and provide the most recent inspection (within the previous 12 months) before initial Tennessee licensure as a compounding pharmacy, licensed compounding pharmacies must report disciplinary action by other regulators to the Board within 14 business days, compounding must follow the USP chapters the Board adopts by rule, and sterile compounders must report the quantity of sterile compounded products dispensed. Board rule chapter 1140-07 sets the sterile compounding standards. Tennessee has no separate state list of compoundable bulk substances, so a peptide's eligibility follows the federal 503A test (approved drug component, USP or NF monograph, or FDA 503A bulks list). [1] [5] [6] [7]

Can you get compounded GLP-1s in Tennessee?

Regulatory: Compounded GLP-1 limited

Tennessee has not adopted a looser rule, and because injectable GLP-1s are sterile preparations, a pharmacy compounding them for a Tennessee patient must also meet rule chapter 1140-07 and, if out of state, the section 63-10-216 inspection requirement. [5] [6] [10]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in Tennessee?

Access options

We may earn a commission from these links.

Prices are the partner's own and are not verified by PeptideAgent. You answer health questions after checkout, and the partner's clinician decides whether to prescribe.

Unsponsored access paths are checked against public regulatory records. Sponsored offers are the partner's and are labeled. Products labeled research use only are never listed.

Find a provider in Tennessee

What you'll actually find in Tennessee, and how to check

Licensed compounding pharmacies, clinics, and telehealth prescribers openly offer many unapproved peptides, and prescribers write prescriptions for them. [12] [13] [14]

No FDA oversight of the specific product: FDA does not check a compounded drug's safety, effectiveness, or quality before it is sold. [15]

What Tennessee has done

PeptideAgent has not found a board or legislative action on peptides in Tennessee.

Other states have acted:

  • On August 19, 2026, Mississippi's medical, nursing, and pharmacy boards said no licensed provider may prescribe, recommend, supply, or administer a peptide that is not FDA approved, and that a consent form does not remove the provider's liability. [17] Mississippi law
  • Louisiana acted by statute: Act 374, in effect August 1, 2026, bars its licensing boards from prohibiting peptides only when they come from a pharmacy or outsourcing facility that complies with federal compounding law. It does not make any peptide eligible to compound. [18] [19] Louisiana law

Checking the prescriber

Telehealth prescribing of non-controlled peptides is permitted in Tennessee. A prescriber may prescribe without a live visit (asynchronous care) when it meets the standard of care. State law says an online questionnaire alone is not enough. [2] [4] The telehealth rule in full.

Checking the pharmacy

Look the pharmacy up yourself before you pay, including an out-of-state mail-order pharmacy. The pharmacy regulator is the Tennessee Board of Pharmacy (Tennessee Department of Health); its license search: FDA BeSafeRx: state board of pharmacy license lookups. [16]

If you're going ahead anyway

These steps lower some risks. They do not make a compounded product safe, and FDA has not reviewed it. [15]

They do not change a peptide's legal status either. That depends on the peptide: for a withdrawn nomination such as BPC-157 or TB-500, a 503A pharmacy has no federal basis to compound it from bulk, with or without a prescription, while a few Category 1 substances, such as NAD+ and glutathione, are compounded under FDA's interim policy, with conditions. Each peptide page gives its status. [8] [20] [21]

Check the pharmacy's license. Look the pharmacy up yourself on your state board of pharmacy's license search; FDA's BeSafeRx page links every state's. If the pharmacy is not listed, or is not licensed in your state, do not use it. [16] [22] [23]

What a legitimate prescription and consult look like. Federal law lets a pharmacy compound only for an identified patient on a valid prescription. A legitimate prescriber is licensed in the state where you are, evaluates you, and tells you the drug is compounded and not FDA approved, and a telehealth company should say which pharmacy compounds it. A seller that needs no prescription, or a pharmacy with no pharmacist to answer questions, is a warning sign. [14] [23] [24]

Why this is safer than a research-use-only product. A state-licensed pharmacy answers to its state board and has a pharmacist you can reach. A product labeled "research use only" or "not for human consumption" has neither, and FDA treats such products sold for people as unapproved drugs. In a 2024 study of semaglutide sold online without a prescription, half of six orders never arrived, and every vial that did was rated probably substandard or falsified, held more drug than its label said, and contained endotoxin. Black-market growth peptides have also contained modified molecules the label did not name. Safer is not safe: compounded drugs can also be contaminated or have too much or too little active ingredient. [15] [25] [26] [27] [28] [29]

Check for:

  • A 503A pharmacy licensed in your state (your state board of pharmacy publishes license lookups). [15]
  • A real evaluation by a licensed prescriber, not just an online form.
  • A certificate of analysis for the specific batch.

Questions to ask

  • Pharmacy: What is your license number, and are you licensed in my state? Then check it yourself on the state board's site. [16]
  • Telehealth company: Which pharmacy compounds and ships this, and is it a 503A pharmacy or a 503B outsourcing facility? [14]
  • Pharmacy: Is this made for me on a prescription written in my name? [24]
  • Prescriber: Are you licensed where I am, and will you evaluate me yourself rather than rely on a questionnaire? [14] [23]
  • Anyone offering it: Does anyone call it "FDA approved", "generic", or from an "FDA-approved pharmacy"? None of these is true of a compounded drug, so the claim is a red flag. [14]

What is offered for a specific peptide, and what FDA found, is on each peptide page.

Is it legal to buy research peptides in Tennessee?

Under title 63, chapter 10, only licensed pharmacies may dispense prescription drugs to Tennessee patients, so a seller shipping "research use only" injectable peptides to Tennessee consumers is not operating under Board of Pharmacy licensure. [1] [11]

Peptide-specific notes for Tennessee

No peptide-specific rule identified for this jurisdiction. The general compounding and telehealth rules above apply, and the federal record covers semaglutide, tirzepatide, and BPC-157.

Frequently asked questions

Can I get a GLP-1 prescription in Tennessee through telehealth?

Yes. Section 63-1-155 lets a Tennessee-licensed provider establish a relationship and treat you by telehealth under the same standard of practice as an office visit. A live visit is not required: Board of Medical Examiners Rule 0880-02-.16(6) lets a physician establish the relationship with health information sent at the level of store-and-forward technology or secure video conferencing. A questionnaire alone is not enough. Rule 0880-02-.14(7)(c) makes it a prima facie violation for a physician to prescribe based solely on answers to a set of questions, without the history, examination, diagnosis, and treatment plan the rule requires. [2] [4]

Can a Tennessee licensing board make telehealth rules stricter than in-person rules?

No. Section 63-1-155 bars the board governing a provider from setting a more restrictive standard of practice for telehealth than the provider's practice act allows. Telehealth care is held to the same standard as in-person care, not a lower or higher one. [2]

What does an out-of-state compounding pharmacy need to ship peptides to Tennessee?

A Tennessee pharmacy license issued after the pharmacy submits an inspection by its home-state regulator from the previous 12 months, as section 63-10-216 requires. It must also report outside disciplinary actions to the Tennessee Board within 14 business days and follow Board-adopted USP compounding standards. [1] [5]

Can a Tennessee pharmacy compound peptides that are not on the FDA bulks list?

Generally no. Tennessee has no state bulks list, so the federal 503A test applies: the substance must be a component of an approved drug, have a USP or NF monograph, or be on the FDA 503A bulks list. Peptides placed in FDA Category 2 cannot be compounded. [5] [7] [8]

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, federal FDA guidance, and the FDA warning letters and studies behind what is offered.

  1. [1]Tennessee Board of Pharmacy (Tennessee Department of Health)
  2. [2]Tennessee Code section 63-1-155, Telehealth and telemedicine services, provider-patient relationship, standard of practice
  3. [3]Tennessee Board of Medical Examiners: Telemedicine FAQ
  4. [4]Tennessee Board of Medical Examiners rules chapter 0880-02 (including Rules 0880-02-.14 and 0880-02-.16), November 2025 revision
  5. [5]Tennessee Code section 63-10-216, Compounding pharmacies
  6. [6]Rules of the Tennessee Board of Pharmacy chapter 1140-07, sterile compounding standards
  7. [7]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  8. [8]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
  9. [9]FDA: Pharmacy Compounding Advisory CommitteeFDA
  10. [10]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA

Cite this page

Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.

APA style
PeptideAgent. (2026, October 4). Are peptides legal in Tennessee?. https://peptideagent.ai/legal/tennessee
HTML link
<a href="https://peptideagent.ai/legal/tennessee">Are peptides legal in Tennessee?</a>, PeptideAgent, updated October 4, 2026.